<CITATION alternative_keys="['pharmaceuticalsbiovail#1']" end="12" reporter="U.S." entry_type="standard_key" lookup_key="u.s._535_931" id1="118737" volume="535" start="0" page_number="931" standard_reporter="U.S." citation_global_level_id="4375.002" line="1" id="118727_1" citation_local_level_id="0" >535 U.S. 931</CITATION>

<CITATION party2="BIOVAIL CORP" party1="ANDRX PHARMACEUTICALS, INC." citation_global_level_id="63168.001" party2_short="BIOVAIL" line="2" id="118727_2" alternative_keys="['u.s._535_931']" end="60" entry_type="party_key" lookup_key="pharmaceuticalsbiovail#1" id1="118727" start="17" party1_short="PHARMACEUTICALS" citation_local_level_id="1" >ANDRX PHARMACEUTICALS, INC. v. BIOVAIL CORP</CITATION>

<NAME end="44" start="17" party1_of="118727_2" all_names="ANDRX PHARMACEUTICALS INC" local_name_id="1" id="118727_3" >ANDRX PHARMACEUTICALS, INC.</NAME>

<ORGANIZATION start="17" end="43" id="118727_5" >ANDRX PHARMACEUTICALS, INC</ORGANIZATION>

<NAME end="60" start="48" all_names="BIOVAIL CORP" party2_of="118727_2" local_name_id="2" id="118727_4" >BIOVAIL CORP</NAME>

<DOCKET end="77" entry_type="docket" lookup_key="pharmaceuticalsbiovail#1" id1="118727" start="70" citation_global_level_id="63168.001" line="3" id="118727_8" citation_local_level_id="1" >01-1050</DOCKET>

<DATE start="123" citation_global_level_id="63168.001" end="137" id="118727_9" citation_local_level_id="1" >March 18, 2002</DATE>

<NAME start="159" local_name_id="3" end="174" id="118727_14" all_names="C A D C CIR" >C. A. D. C. Cir</NAME>

<NAME start="176" local_name_id="4" end="186" id="118727_15" all_names="CERTIORARI" >Certiorari</NAME>

<CITATION end="224" reporter="F. 3d" entry_type="standard_key" no_current_file="True" lookup_key="f.3d_256_799" id1="Dummy_File_233494" volume="256" start="211" page_number="799" standard_reporter="F.3D" citation_global_level_id="297344.001" line="8" id="118727_13" citation_local_level_id="2" >256 F. 3d 799</CITATION>

<RELATION theme="118727_2" party1="118727_3" party1_string="ANDRX PHARMACEUTICALS, INC." theme_string="ANDRX PHARMACEUTICALS, INC. v. BIOVAIL CORP" gram_type="infix" relation_type="asymmetric" id="118727_6" ></RELATION>

<RELATION party2="118727_4" theme="118727_2" theme_string="ANDRX PHARMACEUTICALS, INC. v. BIOVAIL CORP" party2_string="BIOVAIL CORP" gram_type="infix" relation_type="asymmetric" id="118727_7" ></RELATION>

<RELATION standard_case_string="535 U.S. 931" X_vs_Y_string="ANDRX PHARMACEUTICALS, INC. v. BIOVAIL CORP" standard_case="118727_1" X_vs_Y="118727_2" gram_type="multi_line" relation_type="equivalence" id="118727_10" ></RELATION>

<RELATION at_date_string="March 18, 2002" theme="118727_2" at_date="118727_9" theme_string="ANDRX PHARMACEUTICALS, INC. v. BIOVAIL CORP" gram_type="multi_line" relation_type="asymmetric" id="118727_12" ></RELATION>

<RELATION theme="118727_2" includes_docket_string="01-1050" includes_docket="118727_8" theme_string="ANDRX PHARMACEUTICALS, INC. v. BIOVAIL CORP" gram_type="multi_line" relation_type="asymmetric" id="118727_11" ></RELATION>

